This single-dose presentation has been authorised by the European Medicines Agency (EMA) with pet rabbits included in the indications as a target species.
ERAVAC is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is becoming the choice for active immunisation of pet rabbits from 30 days of age.
With these variations, HIPRA reaffirms its commitment to the prevention of RHD-2 and demonstrates its support for the companion animal sector.
HIPRA will be present at the London Vet Show conference which is being held in London on 15 and 16 November 2018.
